Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 13,500 shares at $57.07 ($781K) on 2014-05-19, disclosed to the SEC on 2014-05-21.
Scheduled sale ($781k) by SVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.07 | 2,600 | $148K | 19.0% |
| 2 | $58.01 | 10,900 | $632K | 81.0% |
| Total | $57.83 avg | 13,500 | $781K | 100% |
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-02-20 | $1.6M | — | Filing → |